Supplementing Vitamin D in Different Patient Groups to Reduce Deficiency

Pawel Pludowski, Pawel Pludowski

Abstract

Introduction: Studies indicate a high prevalence of vitamin D deficiency in both the general population and at-risk groups. Given the association between vitamin D deficiency and various diseases, addressing this concern becomes crucial, especially in situations where routine monitoring is challenging.

Materials and methods: A systematic literature review of the current knowledge on vitamin D dosing in diverse at-risk populations and the application of the findings to a broader clinical perspective.

Results: The reviewed studies revealed a high prevalence of vitamin D deficiency among patients with musculoskeletal disorders, systemic connective tissue diseases, corticosteroid use, endocrine and metabolic conditions, malabsorption syndromes, obesity, chronic kidney disease, cancer, and central nervous system diseases. Vitamin D deficiency was often more severe compared to the general population. Higher dosages of vitamin D beyond the recommended levels for the general population were shown to be effective in improving vitamin D status in these at-risk individuals. Additionally, some studies suggested a potential link between intermittent vitamin D administration and improved adherence.

Conclusion: Simplified dosing could empower clinicians to address vitamin D deficiency, particularly in high-risk populations, even without routine monitoring. Further research is needed to establish the optimal dosing regimens for specific at-risk populations.

Keywords: cholecalciferol; general population; risk groups; routine monitoring; vitamin D deficiency.

Conflict of interest statement

The author declares no conflict of interest.

References

    1. Płudowski P., Kos-Kudła B., Walczak M., Fal A., Zozulińska-Ziółkiewicz D., Sieroszewski P., Peregud-Pogorzelski J., Lauterbach R., Targowski T., Lewiński A., et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 2023;15:695. doi: 10.3390/nu15030695.
    1. De Martinis M., Allegra A., Sirufo M.M., Tonacci A., Pioggia G., Raggiunti M., Ginaldi L., Gangemi S. Vitamin D Deficiency, Osteoporosis and Effect on Autoimmune Diseases and Hematopoiesis: A Review. Int. J. Mol. Sci. 2021;22:8855. doi: 10.3390/ijms22168855.
    1. Pludowski P., Takacs I., Boyanov M., Belaya Z., Diaconu C.C., Mokhort T., Zherdova N., Rasa I., Payer J., Pilz S. Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency: A Central and Eastern European Expert Consensus Statement. Nutrients. 2022;14:1483. doi: 10.3390/nu14071483.
    1. Takacs I., Bakos B., Nemeth Z., Toth B.E., Szili B., Lakatos P. Controlled randomized open label clinical study comparing the safety and efficacy of loading schedules in vitamin D deficient patients. J. Steroid Biochem. Mol. Biol. 2023;231:106330. doi: 10.1016/j.jsbmb.2023.106330.
    1. Rothen J.-P., Rutishauser J., Walter P.N., Hersberger K.E., Arnet I. Vitamin D oral intermittent treatment (DO IT) study, a randomized clinical trial with individual loading regimen. Sci. Rep. 2021;11:18746. doi: 10.1038/s41598-021-97417-x.
    1. Takács I., Tóth B.E., Szekeres L., Szabó B., Bakos B., Lakatos P. Randomized clinical trial to comparing efficacy of daily, weekly and monthly administration of vitamin D3. Endocrine. 2016;55:60–65. doi: 10.1007/s12020-016-1137-9.
    1. Fassio A., Adami G., Rossini M., Giollo A., Caimmi C., Bixio R., Viapiana O., Milleri S., Gatti M., Gatti D. Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study. Nutrients. 2020;12:1553. doi: 10.3390/nu12061553.
    1. Rothen J.-P., Rutishauser J., Walter P.N., Hersberger K.E., Arnet I. Oral intermittent vitamin D substitution: Influence of pharmaceutical form and dosage frequency on medication adherence: A randomized clinical trial. BMC Pharmacol. Toxicol. 2020;21:51. doi: 10.1186/s40360-020-00430-5.
    1. Dougherty K.A., Schall J.I., Bertolaso C., Smith-Whitley K., Stallings V.A. Vitamin D Supplementation Improves Health-Related Quality of Life and Physical Performance in Children with Sickle Cell Disease and in Healthy Children. J. Pediatr. Health Care. 2020;34:424–434. doi: 10.1016/j.pedhc.2020.04.007.
    1. Wamberg L., Pedersen S.B., Richelsen B., Rejnmark L. The Effect of High-Dose Vitamin D Supplementation on Calciotropic Hormones and Bone Mineral Density in Obese Subjects with Low Levels of Circulating 25-Hydroxyvitamin D: Results from a Randomized Controlled Study. Calcif. Tissue Int. 2013;93:69–77. doi: 10.1007/s00223-013-9729-3.
    1. Toth B.E., Takacs I., Szekeres L., Szabo B., Bakos B., Lakatos P. Safety and Efficacy of Weekly 30,000 IU Vitamin D Supplementation as a Slower Loading Dose Administration Compared to a Daily Maintenance Schedule in Deficient Patients: A Randomized, Controlled Clinical Trial. J. Pharmacovigil. 2017;5:2. doi: 10.4172/2329-6887.1000233.
    1. Lombardo M., Feraco A., Ottaviani M., Rizzo G., Camajani E., Caprio M., Armani A. The Efficacy of Vitamin D Supplementation in the Treatment of Fibromyalgia Syndrome and Chronic Musculoskeletal Pain. Nutrients. 2022;14:3010. doi: 10.3390/nu14153010.
    1. Scragg R. The Vitamin D Assessment (ViDA) study—Design and main findings. J. Steroid Biochem. Mol. Biol. 2020;198:105562. doi: 10.1016/j.jsbmb.2019.105562.
    1. Malihi Z., Lawes C.M.M., Wu Z., Huang Y., Waayer D., Toop L., Khaw K.-T., Camargo C.A., Scragg R. Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: Results from a randomized controlled trial. Am. J. Clin. Nutr. 2019;109:1578–1587. doi: 10.1093/ajcn/nqy378.
    1. Wu Z., Malihi Z., Stewart A.W., Lawes C.M., Scragg R. The association between vitamin D concentration and pain: A systematic review and meta-analysis. Public Health Nutr. 2018;21:2022–2037. doi: 10.1017/S1368980018000551.
    1. Dong Y., Zhu H., Chen L., Huang Y., Christen W., Cook N.R., Copeland T., Mora S., Buring J.E., Lee I.-M., et al. Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial. Nutrients. 2022;14:5307. doi: 10.3390/nu14245307.
    1. Sobh M.M., Abdalbary M., Elnagar S., Nagy E., Elshabrawy N., Abdelsalam M., Asadipooya K., El-Husseini A. Secondary Osteoporosis and Metabolic Bone Diseases. J. Clin. Med. 2022;11:2382. doi: 10.3390/jcm11092382.
    1. Skversky A.L., Kumar J., Abramowitz M.K., Kaskel F.J., Melamed M.L. Association of Glucocorticoid Use and Low 25-Hydroxyvitamin D Levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001–2006. J. Clin. Endocrinol. Metab. 2011;96:3838–3845. doi: 10.1210/jc.2011-1600.
    1. Bilezikian J.P., Formenti A.M., Adler R.A., Binkley N., Bouillon R., Lazaretti-Castro M., Marcocci C., Napoli N., Rizzoli R., Giustina A. Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all? Rev. Endocr. Metab. Disord. 2021;22:1201–1218. doi: 10.1007/s11154-021-09693-7.
    1. Nasr M.H., Hassan B.A.R., Othman N., Karuppannan M., Abdulaziz N.B., Mohammed A.H., Alsarani M.A., Eskembaji M.H., Aman A.M., Othman G. Prevalence of Vitamin D Deficiency Between Type 2 Diabetes Mellitus Patients and Non-Diabetics in the Arab Gulf. Diabetes Metab. Syndr. Obes. Targets Ther. 2022;15:647–657. doi: 10.2147/DMSO.S350626.
    1. Utmani S.B., Thyagaraj V. A Study of the Association Between Metabolic Syndrome and Vitamin D Deficiency. J. Assoc. Physicians India. 2022;70:11–12.
    1. Galușca D., Popoviciu M.S., Babeș E.E., Vidican M., Zaha A.A., Babeș V.V., Jurca A.D., Zaha D.C., Bodog F. Vitamin D Implications and Effect of Supplementation in Endocrine Disorders: Autoimmune Thyroid Disorders (Hashimoto’s Disease and Grave’s Disease), Diabetes Mellitus and Obesity. Medicina. 2022;58:194. doi: 10.3390/medicina58020194.
    1. Dawson-Hughes B., Staten M.A., Knowler W.C., Nelson J., Vickery E.M., LeBlanc E.S., Neff L.M., Park J., Pittas A.G. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults with Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care. 2020;43:2916–2922. doi: 10.2337/dc20-1765.
    1. Irwinda R., Hiksas R., Lokeswara A.W., Wibowo N. Vitamin D supplementation higher than 2000 IU/day compared to lower dose on maternal–fetal outcome: Systematic review and meta-analysis. Women’s Health. 2022;18:17455057221111066. doi: 10.1177/17455057221111066.
    1. El Hajj C., Walrand S., Helou M., Yammine K. Effect of Vitamin D Supplementation on Inflammatory Markers in Non-Obese Lebanese Patients with Type 2 Diabetes: A Randomized Controlled Trial. Nutrients. 2020;12:2033. doi: 10.3390/nu12072033.
    1. Rolighed L., Rejnmark L., Sikjaer T., Heickendorff L., Vestergaard P., Mosekilde L., Christiansen P. Vitamin D Treatment in Primary Hyperparathyroidism: A Randomized Placebo Controlled Trial. J. Clin. Endocrinol. Metab. 2014;99:1072–1080. doi: 10.1210/jc.2013-3978.
    1. Bleizgys A. Vitamin D Dosing: Basic Principles and a Brief Algorithm (2021 Update) Nutrients. 2021;13:4415. doi: 10.3390/nu13124415.
    1. Rusińska A., Płudowski P., Walczak M., Borszewska-Kornacka M.K., Bossowski A., Chlebna-Sokół D., Czech-Kowalska J., Dobrzańska A., Franek E., Helwich E., et al. Vitamin D Supplementation Guidelines for General Population and Groups at Risk of Vitamin D Deficiency in Poland—Recommendations of the Polish Society of Pediatric Endocrinology and Diabetes and the Expert Panel with Participation of National Specialist Consultants and Representatives of Scientific Societies—2018 Update. Front. Endocrinol. 2018;9:246. doi: 10.3389/fendo.2018.00246.
    1. Dominguez L.J., Farruggia M., Veronese N., Barbagallo M. Vitamin D Sources, Metabolism, and Deficiency: Available Compounds and Guidelines for Its Treatment. Metabolites. 2021;11:255. doi: 10.3390/metabo11040255.
    1. Raftery T., Martineau A.R., Greiller C.L., Ghosh S., McNamara D., Bennett K., Meddings J., O’sullivan M. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. United Eur. Gastroenterol. J. 2015;3:294–302. doi: 10.1177/2050640615572176.
    1. Gregson C.L., Armstrong D.J., Bowden J., Cooper C., Edwards J., Gittoes N.J.L., Harvey N., Kanis J., Leyland S., Low R., et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch. Osteoporos. 2022;17:58. doi: 10.1007/s11657-022-01061-5.
    1. Caravaca F., Caravaca-Fontán F., Azevedo L., Luna E. Changes in renal function after discontinuation of vitamin D analogues in advanced chronic kidney disease. Nefrología. 2018;38:179–189. doi: 10.1016/j.nefro.2017.05.012.
    1. Okša A., Spustová V., Krivošíková Z., Gazdíková K., Fedelešová V., Lajdová I., Štefíková K., Bernasovská G., Žilinská Z., Dzúrik R. Effects of Long-Term Cholecalciferol Supplementation on Mineral Metabolism and Calciotropic Hormones in Chronic Kidney Disease. Kidney Blood Press. Res. 2008;31:322–329. doi: 10.1159/000157177.
    1. Jean G., Souberbielle J.-C., Chazot C. Monthly cholecalciferol administration in haemodialysis patients: A simple and efficient strategy for vitamin D supplementation. Nephrol. Dial. Transplant. 2009;24:3799–3805. doi: 10.1093/ndt/gfp370.
    1. Delanaye P., Weekers L., Warling X., Moonen M., Smelten N., Médart L., Krzesinski J.-M., Cavalier E. Cholecalciferol in haemodialysis patients: A randomized, double-blind, proof-of-concept and safety study. Nephrol. Dial. Transplant. 2013;28:1779–1786. doi: 10.1093/ndt/gft001.
    1. Chandler P.D., Chen W.Y., Ajala O.N., Hazra A., Cook N., Bubes V., Lee I.M., Giovannucci E.L., Willett W., Buring J.E., et al. Effect of Vitamin D3 Supplements on Development of Advanced Cancer: A Secondary Analysis of the VITAL Randomized Clinical Trial. JAMA Netw. Open. 2020;3:e2025850. doi: 10.1001/jamanetworkopen.2020.25850.
    1. Muñoz A., Grant W.B. Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms. Nutrients. 2022;14:1448. doi: 10.3390/nu14071448.
    1. Timerman D., McEnery-Stonelake M., Joyce C.J., Nambudiri V.E., Hodi F.S., Claus E.B., Ibrahim N., Lin J.Y. Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma. Oncotarget. 2016;8:6873–6882. doi: 10.18632/oncotarget.14316.
    1. Sluyter J.D., Manson J.A.E., Scragg R. Vitamin D and Clinical Cancer Outcomes: A Review of Meta-Analyses. JBMR Plus. 2020;5:e10420. doi: 10.1002/jbm4.10420.
    1. Manson J.E., Cook N.R., Lee I.M., Christen W., Bassuk S.S., Mora S., Gibson H., Gordon D., Copeland T., D’Agostino D., et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N. Engl. J. Med. 2019;380:33–44. doi: 10.1056/NEJMoa1809944.
    1. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011;96:1911–1930. doi: 10.1210/jc.2011-0385.
    1. Wang Y., Huang X., Wu Y., Li A., Tian Y., Ren M., Li Z., Zhang T., Wu H., Wang W. Increased Risk of Vitamin D Deficiency Among HIV-Infected Individuals: A Systematic Review and Meta-Analysis. Front. Nutr. 2021;8:722032. doi: 10.3389/fnut.2021.722032.
    1. Schall J.I., Hediger M.L., Zemel B.S., Rutstein R.M., Stallings V.A. Comprehensive Safety Monitoring of 12-Month Daily 7000-IU Vitamin D3Supplementation in Human Immunodeficiency Virus–Infected Children and Young Adults. J. Parenter. Enter. Nutr. 2015;40:1057–1063. doi: 10.1177/0148607115593790.
    1. Alvarez N., Aguilar-Jimenez W., Rugeles M.T. The Potential Protective Role of Vitamin D Supplementation on HIV-1 Infection. Front. Immunol. 2019;10:2291. doi: 10.3389/fimmu.2019.02291.
    1. Geng T., Lu Q., Wan Z., Guo J., Liu L., Pan A., Liu G. Association of serum 25-hydroxyvitamin D concentrations with risk of dementia among individuals with type 2 diabetes: A cohort study in the UK Biobank. PLoS Med. 2022;19:e1003906. doi: 10.1371/journal.pmed.1003906.
    1. Jésus P., Godet B., Darthou-Pouchard L., Fayemendy P., Abdallah-Lebeau F., Villeneuve O., Marcon C., Gimenez L., Preux P.M., Couratier P., et al. Vitamin D status among patients with drug-resistant and non-drug-resistant epilepsy. Int. J. Vitam. Nutr. Res. 2020;90:205–209. doi: 10.1024/0300-9831/a000459.
    1. Hiller A.L., Murchison C.F., Lobb B.M., O’connor S., O’connor M., Quinn J.F. A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson’s disease: Does age matter? PLoS ONE. 2018;13:e0203637. doi: 10.1371/journal.pone.0203637.
    1. Penckofer S., Byrn M., Adams W., Emanuele M.A., Mumby P., Kouba J., Wallis D.E. Vitamin D Supplementation Improves Mood in Women with Type 2 Diabetes. J. Diabetes Res. 2017;2017:8232863. doi: 10.1155/2017/8232863.
    1. Suzuki M., Yoshioka M., Hashimoto M., Murakami M., Noya M., Takahashi D., Urashima M. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am. J. Clin. Nutr. 2013;97:1004–1013. doi: 10.3945/ajcn.112.051664.
    1. Holick M.F. Vitamin D Is Not as Toxic as Was Once Thought: A Historical and an Up-to-Date Perspective. Mayo Clin. Proc. 2015;90:561–564. doi: 10.1016/j.mayocp.2015.03.015.
    1. Marcinowska-Suchowierska E., Kupisz-Urbańska M., Łukaszkiewicz J., Płudowski P., Jones G. Vitamin D Toxicity—A Clinical Perspective. Front. Endocrinol. 2018;9:550. doi: 10.3389/fendo.2018.00550.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner